Development and validation of a deep learning AI model in lung cancer

aiforia
12/15/21, 1:00 PM
America/New York GMT -4 summer

Description

PD-L1 expression is the most important biomarker for response to immunotherapy in advanced metastatic NSCLC. In this webinar, the development and validation of our supervised algorithm for PD-L1 scoring will be discussed.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Development and validation of a deep learning AI model in lung cancer

Inglês

 

Speakers

Liesbeth Hondelink

 

Link to the Event

Banner to the Event

Development and validation of a deep learning AI model in lung cancer